Aldeyra Therapeutics, Inc. (ALDX) KPIs and segments

ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30

$0.64+0.01 (+2.17%)

Close on Nov 13, 2026Market cap $38.84MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Aldeyra Therapeutics's business

Coming soon

This tab will track the numbers specific to Aldeyra Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?